ANKMY2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.290800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.037200E-01
Normal-vs-Stage2
4.187200E-01
Normal-vs-Stage3
8.936400E-01
Normal-vs-Stage4
1.257790E-01
Stage1-vs-Stage2
9.239600E-01
Stage1-vs-Stage3
3.261400E-01
Stage1-vs-Stage4
5.174000E-01
Stage2-vs-Stage3
2.985600E-01
Stage2-vs-Stage4
3.974000E-01
Stage3-vs-Stage4
1.073450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.555200E-01
Normal-vs-AfricanAmerican
2.371600E-01
Normal-vs-Asian
4.000200E-01
Caucasian-vs-AfricanAmerican
3.709000E-01
Caucasian-vs-Asian
3.970800E-01
AfricanAmerican-vs-Asian
9.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.342600E-01
Normal-vs-Female
4.308000E-01
Male-vs-Female
7.135800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.948200E-01
Normal-vs-Age(41-60Yrs)
1.572800E-01
Normal-vs-Age(61-80Yrs)
6.085000E-01
Normal-vs-Age(81-100Yrs)
6.389400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.890200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.787800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.689800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.118640E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.148100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.183800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.800200E-01
Normal-vs-Daily Drinker
5.946000E-01
Normal-vs-Weekly Drinker
5.591200E-01
Normal-vs-Occasional Drinker
1.776160E-01
Normal-vs-Social Drinker
1.653560E-01
Non Drinker-vs-Daily Drinker
9.087400E-01
Non Drinker-vs-Weekly Drinker
7.871000E-01
Non Drinker-vs-Occasional Drinker
8.899500E-02
Non Drinker-vs-Social Drinker
2.805800E-01
Daily Drinker-vs-Weekly Drinker
8.555600E-01
Daily Drinker-vs-Occasional Drinker
1.000210E-01
Daily Drinker-vs-Social Drinker
3.740200E-01
Weekly Drinker-vs-Occasional Drinker
2.112400E-01
Weekly Drinker-vs-Social Drinker
5.470600E-01
Occasional Drinker-vs-Social Drinker
3.779400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.641800E-02
Normal-vs-Grade 2
1.170210E-02
Normal-vs-Grade 3
1.565870E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.735700E-02
Grade 1-vs-Grade 3
5.219700E-02
Grade 1-vs-Grade 4
3.641800E-02
Grade 2-vs-Grade 3
4.891600E-01
Grade 2-vs-Grade 4
1.170210E-02
Grade 3-vs-Grade 4
1.565870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.182000E-01
Normal-vs-NonDiabetic
3.702200E-01
Diabetic-vs-NonDiabetic
3.545900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.414990E-01
Normal-vs-NoPancreatitis
5.028000E-01
Pancreatitis-vs-NoPancreatitis
2.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.199800E-01
Normal-vs-N1
4.265200E-01
N0-vs-N1
6.121200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.108760E-01
Normal-vs-TP53-NonMutant
3.293600E-01
TP53-Mutant-vs-TP53-NonMutant
5.252400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
